Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management (Q33548205)

28 July 2017

1 reference

title

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management (English)

1 reference

Helicobacter pylori infectious disease

28 July 2017

0 references

1 reference

O'Connor HJ

1

1 reference

PubMed ID

10102940

28 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Alimentary Pharmacology & Therapeutics

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

2

1 reference

28 July 2017

117-127

1 reference

Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Reflux oesophagitis and Helicobacter pylori infection in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Patterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Gastroesophageal reflux in duodenal ulcer patients before and after vagotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

The association of oesophagitis with disease in the stomach and duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Long-term sequelae of Helicobacter pylori gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

The effect of gastrin on growth of human stomach cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Contribution of HLA-DQA gene to host's response against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Muscarinic receptors in gastric mucosa are increased in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Campylobacter-like organisms and heterotopic gastric mucosa in Meckel's diverticula

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

Helicobacter pylori infection in patients with Barrett's oesophagus: a prospective immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00460.X

10.1046/J.1365-2036.1999.00460.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10102940